Innovative Eyewear faces April 7, 2027 Nasdaq deadline

Innovative Eyewear said it will closely monitor its closing bid price and consider options to cure the deficiency.

(High)

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Innovative Eyewear, Inc. received a written notice from Nasdaq’s Listing Qualifications Department that its common stock failed the $1.00 minimum bid-price requirement after closing below that level for 30 consecutive business days. The notice has no immediate effect on the Nasdaq Capital Market listing. The company has until April 7, 2027, a 180-calendar-day compliance period, to meet the requirement by closing at or above $1.00 for at least 10 consecutive business days; Nasdaq staff may extend the 10-day period.

If the company does not regain compliance, it may qualify for a second 180-calendar-day period if it meets initial-listing criteria other than the bid-price requirement, satisfies the continued-listing requirement for market value of publicly held shares, and gives Nasdaq written notice of its intent to cure, including through a reverse stock split if necessary. If it is ineligible for that period or appears unable to cure the deficiency, Nasdaq may issue a delisting notice. A timely hearing request would stay further suspension or delisting action pending the hearing process and any extension granted by the Panel.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance works How Sentiment works

0 major · 1 point

How the balance works

Positive

None.

Negative

Moderate pointNasdaq bid-price deficiency: closing bids stayed below $1.00 for 30 business days.

Insights

Analyzing...

8-K Event Classification

Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

1 item

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities

The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.

Key Figures

Consecutive business days below minimum bid: 30 business days Minimum bid price: $1.00 per share Initial compliance period: 180 calendar days +2 more

5 metrics

Consecutive business days below minimum bid 30 business days The common stock’s closing bid price was below the continued-listing requirement.

Minimum bid price $1.00 per share Nasdaq Capital Market continued-listing requirement.

Initial compliance period 180 calendar days Until April 7, 2027, to regain compliance.

Required consecutive closing bid days At least 10 consecutive business days Closing bid price must be at least $1.00 per share.

Potential additional compliance period 180 calendar days May be available if the stated eligibility criteria are met.

Key Terms

Minimum Bid Requirement, Nasdaq Hearings Panel, market value of publicly held shares

3 terms

Minimum Bid Requirement regulatory

"minimum bid price requirement for continued listing"

A minimum bid requirement is a rule that a stock’s price must meet or exceed a set floor for certain market actions — for example to remain listed on an exchange, qualify for a tender offer, or participate in a specific auction. It matters to investors because falling below that floor can trigger delisting, limit who can buy or sell the shares, or change the terms of a transaction; think of it like a store’s minimum purchase needed to access a special sale, which affects value and liquidity.

Nasdaq Hearings Panel regulatory

"request a hearing before the Nasdaq Hearings Panel"

A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.

market value of publicly held shares regulatory

"continued listing requirement for market value of publicly held shares"

The market value of publicly held shares is the total dollar worth of a company’s shares that are available to outside investors, calculated by multiplying the current market price by the number of shares held by the public (the “float”). It matters because it tells investors how much of the company is actually tradable and how the market is pricing that tradable portion—like a price tag on the items on a store shelf, it affects liquidity, volatility and how easy it is to buy or sell a meaningful stake.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How long does LUCY have to regain Nasdaq’s $1 bid-price compliance?

Innovative Eyewear has until April 7, 2027, to regain compliance. The 180-calendar-day period requires a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days.

Can LUCY receive another Nasdaq compliance period?

Innovative Eyewear may be eligible for an additional 180-calendar-day period if it satisfies the initial-listing criteria other than the Minimum Bid Requirement, meets the continued-listing requirement for market value of publicly held shares, and gives Nasdaq written notice of its intent to cure the deficiency by effecting a reverse stock split, if necessary.

What happens if Nasdaq seeks to delist LUCY?

If Nasdaq staff determines the company appears unable to cure the deficiency, or that it is not eligible for a second compliance period, staff will provide written notice that the common stock is subject to delisting. The company may request a hearing; a timely request would stay further suspension or delisting action pending the hearing process and any extension granted by the Panel.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/15/2026 - 04:06 PM EDT Accepted by SEC EDGAR 10/15/2026 - 04:05 PM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) October 9, 2026

INNOVATIVE EYEWEAR, INC.

(Exact name of registrant as specified in charter)

Florida		001-41392		84-0734861
(State or other Jurisdiction of Incorporation or Organization)		(Commission File Number)		(IRS Employer Identification No.)

11900 Biscayne Blvd., Suite 630

North Miami, Florida

33181

(Address of Principal Executive Offices)

(zip code)

(786) 785-5178

(Registrant’s telephone number, including area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.00001 per share	LUCY	The Nasdaq Stock Market LLC
Warrants to purchase Common Stock	LUCYW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On October 9, 2026, Innovative Eyewear, Inc., a Florida corporation (the “Company”), received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2). which sets forth the minimum bid price requirement for continued listing on the Nasdaq Capital Market (the “Minimum Bid Requirement”) as the bid price of the Company’s common stock, par value $0.00001 per share (the “Common Stock”), had closed below $1.00 per share for 30 consecutive business days. Nasdaq’s notice has no immediate effect on the listing of the Company’s Common Stock on Nasdaq.

The Notice from the Staff has no immediate effect on the listing of our Common Stock on the Nasdaq Capital Market. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, until April 7, 2027, to regain compliance with the Minimum Bid Requirement. To regain compliance, the closing bid price of our Common Stock must be at least $1.00 per share for a minimum of 10 consecutive business days during this 180-day period, at which time the Staff will provide written notification to the Company that it complies with the Minimum Bid Requirement, unless the Staff exercises its discretion to extend this ten-day period pursuant to Nasdaq Listing Rule 5810(c)(3)(H).

If the Company does not regain compliance with the bid price requirement by April 7, 2027, the Company may be eligible for an additional 180-calendar day compliance period so long as it satisfies the criteria for initial listing on the Nasdaq Capital Market, except the Minimum Bid Requirement, and the continued listing requirement for market value of publicly held shares and the Company provides written notice to Nasdaq of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. In the event it appears to the Staff that the Company will not be able to cure the deficiency, or if the Company is not otherwise eligible for the second grace period, the Staff will provide written notice to the Company that the Common Stock is subject to delisting; however, the Company may request a hearing before the Nasdaq Hearings Panel (the “Panel”), which request, if timely made, would stay any further suspension or delisting action by the Staff pending the conclusion of the hearing process and expiration of any extension that may be granted by the Panel. There can be no assurance that the Company will be eligible for the additional 180 calendar day compliance period, if applicable, or that the Staff would grant the Company’s request for continued listing subsequent to any delisting notification, or, if the Company does appeal the delisting determination by the Staff to the Panel, that such appeal would be successful, or that the Company will be able to regain compliance with the Minimum Bid Requirement or maintain compliance with the other Nasdaq listing requirements.

The Company intends to closely monitor the closing bid price of the Common Stock and consider all available options to remedy the bid price deficiency to regain compliance with the Minimum Bid Requirement.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 15, 2026	INNOVATIVE EYEWEAR, INC.

	By:	/s/ Harrison Gross
		Harrison Gross
		Chief Executive Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents